CNXU
Conexeu Sciences Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$302.10M
P/E Ratio
—
EPS
$-0.26
Beta
—
52W High
$18.79
52W Low
$10.87
50-Day MA
$13.93
200-Day MA
$13.93
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Conexeu Sciences Inc. Common Stock
Conexeu Sciences Inc. (Ticker: CNXU) is a dynamic biotech firm dedicated to advancing healthcare through innovative solutions in diagnostics and therapeutics. The company focuses on harnessing cutting-edge technology to develop products that improve patient outcomes while reducing healthcare costs. With a strong emphasis on research and development, Conexeu is positioned at the forefront of critical medical advancements, making it a compelling prospect for institutional investors seeking exposure to the growing biotechnology sector. Through strategic partnerships and a robust pipeline, the company aims to deliver transformative health solutions that address unmet medical needs.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-5.31M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.34 |
| Price-to-Book | 44.88 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $26.76M |
| Float | $20.09M |
| % Insiders | 40.98% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
More HEALTHCARE Stocks
Data last updated: 6/15/2026